CN102366478A - Composition for whitening skin and resisting senescence, preparation method and application thereof - Google Patents
Composition for whitening skin and resisting senescence, preparation method and application thereof Download PDFInfo
- Publication number
- CN102366478A CN102366478A CN2011103591419A CN201110359141A CN102366478A CN 102366478 A CN102366478 A CN 102366478A CN 2011103591419 A CN2011103591419 A CN 2011103591419A CN 201110359141 A CN201110359141 A CN 201110359141A CN 102366478 A CN102366478 A CN 102366478A
- Authority
- CN
- China
- Prior art keywords
- flower
- parts
- paeonia lactiflora
- salviae miltiorrhizae
- temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 60
- 230000002087 whitening effect Effects 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims abstract description 36
- 230000009758 senescence Effects 0.000 title abstract 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims abstract description 55
- 239000009636 Huang Qi Substances 0.000 claims abstract description 49
- 239000005711 Benzoic acid Substances 0.000 claims abstract description 26
- 235000010233 benzoic acid Nutrition 0.000 claims abstract description 26
- 244000236658 Paeonia lactiflora Species 0.000 claims description 69
- 235000008598 Paeonia lactiflora Nutrition 0.000 claims description 69
- 101150072055 PAL1 gene Proteins 0.000 claims description 68
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 35
- 238000000034 method Methods 0.000 claims description 34
- 239000012467 final product Substances 0.000 claims description 13
- 230000002605 anti-dotal effect Effects 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 12
- 241000545442 Radix Species 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 8
- 238000007789 sealing Methods 0.000 claims description 8
- 244000269722 Thea sinensis Species 0.000 claims description 6
- 238000004898 kneading Methods 0.000 claims description 5
- 230000002045 lasting effect Effects 0.000 claims description 5
- 239000012535 impurity Substances 0.000 claims description 4
- 238000005452 bending Methods 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000000470 constituent Substances 0.000 abstract description 10
- 230000036541 health Effects 0.000 abstract description 6
- 239000000463 material Substances 0.000 abstract description 5
- 230000006378 damage Effects 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 244000241838 Lycium barbarum Species 0.000 abstract description 2
- 235000015459 Lycium barbarum Nutrition 0.000 abstract description 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 241000736199 Paeonia Species 0.000 abstract 3
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 3
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 241000785917 Savia Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 39
- 239000000243 solution Substances 0.000 description 26
- 230000032683 aging Effects 0.000 description 23
- 238000012360 testing method Methods 0.000 description 23
- 230000000694 effects Effects 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- -1 Hydroxy peoniflorin Chemical compound 0.000 description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000003814 drug Substances 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 10
- 239000000523 sample Substances 0.000 description 10
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- 229960000271 arbutin Drugs 0.000 description 7
- 229940035423 ethyl ether Drugs 0.000 description 7
- 210000002752 melanocyte Anatomy 0.000 description 7
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 7
- 238000005303 weighing Methods 0.000 description 7
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 238000011026 diafiltration Methods 0.000 description 6
- 230000003064 anti-oxidating effect Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 229940126678 chinese medicines Drugs 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 239000013558 reference substance Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N Tanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 description 4
- 102000003425 Tyrosinase Human genes 0.000 description 4
- 108060008724 Tyrosinase Proteins 0.000 description 4
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 230000037394 skin elasticity Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 235000017276 Salvia Nutrition 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930183118 Tanshinone Natural products 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- ZZAJQOPSWWVMBI-UHFFFAOYSA-N calycosin Chemical compound C1=C(O)C(OC)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZZAJQOPSWWVMBI-UHFFFAOYSA-N 0.000 description 2
- 230000000711 cancerogenic effect Effects 0.000 description 2
- 231100000315 carcinogenic Toxicity 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002213 flavones Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000006101 laboratory sample Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000003672 processing method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 229960004793 sucrose Drugs 0.000 description 2
- 238000011003 system suitability test Methods 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- LAWPHHZXTUPSDG-UHFFFAOYSA-N Astragaloside I Natural products CC(=O)OC1C(O)COC(OC2CCC34CC35CCC6(C)C(C)(CCC6(O)C7(C)CCC(O7)C(C)(C)O)C5CC(OC8OC(CO)C(O)C(O)C8O)C4C2(C)C)C1OC(=O)C LAWPHHZXTUPSDG-UHFFFAOYSA-N 0.000 description 1
- KXHCYYSIAXMSPA-UHFFFAOYSA-N Astragaloside-I Chemical compound CC(=O)OC1C(OC(=O)C)C(O)COC1OC1C(C)(C)C2C(OC3C(C(O)C(O)C(CO)O3)O)CC3C4(C)CC(O)C(C5(C)OC(CC5)C(C)(C)O)C4(C)CCC43CC42CC1 KXHCYYSIAXMSPA-UHFFFAOYSA-N 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 1
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000004262 Food Hypersensitivity Diseases 0.000 description 1
- 206010016946 Food allergy Diseases 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- 241001072909 Salvia Species 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 241000254062 Scarabaeidae Species 0.000 description 1
- 208000031320 Teratogenesis Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 235000012677 beetroot red Nutrition 0.000 description 1
- 239000001654 beetroot red Substances 0.000 description 1
- 235000002185 betanin Nutrition 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- HJCCJZGOBHFQSX-UHFFFAOYSA-N cyclosieversioside B Natural products CC(CCC(O)C(C)(C)OC1OC(CO)C(O)C(O)C1O)C2C(CC3(C)C4CC(O)C5C(C)(C)C(CCC56CC46CCC23C)OC7OCC(O)C(O)C7O)OC8OC(CO)C(O)C(O)C8O HJCCJZGOBHFQSX-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 229960004502 levodopa Drugs 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Chemical class 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229930182490 saponin Chemical class 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011103591419A CN102366478B (en) | 2011-11-14 | 2011-11-14 | Composition for whitening skin and resisting senescence, preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011103591419A CN102366478B (en) | 2011-11-14 | 2011-11-14 | Composition for whitening skin and resisting senescence, preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102366478A true CN102366478A (en) | 2012-03-07 |
CN102366478B CN102366478B (en) | 2013-04-03 |
Family
ID=45759098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011103591419A Expired - Fee Related CN102366478B (en) | 2011-11-14 | 2011-11-14 | Composition for whitening skin and resisting senescence, preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102366478B (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103263536A (en) * | 2013-02-04 | 2013-08-28 | 四川逢春制药有限公司 | Skin-whitening freckle-removing anti-aging composite and preparation method and application thereof |
CN103316150A (en) * | 2013-06-21 | 2013-09-25 | 四川逢春制药有限公司 | Composition for preventing aging and whitening skin as well as preparation method and application thereof |
CN103989164A (en) * | 2014-05-09 | 2014-08-20 | 深圳市皇都御颜养生科技有限责任公司 | Preparation method of anti-aging health food |
CN104840380A (en) * | 2015-01-21 | 2015-08-19 | 青岛科技大学 | Natural substance composition and application of same in whitening cosmetic |
CN105169064A (en) * | 2015-10-11 | 2015-12-23 | 淄博齐鼎立专利信息咨询有限公司 | Medicinal preparation for whitening skin |
CN105326686A (en) * | 2014-04-09 | 2016-02-17 | 赵月 | Whitening and moisturizing skin care mask |
CN106794136A (en) * | 2014-10-10 | 2017-05-31 | 巴斯夫美容护理法国公司 | The deglycosylation of the combination product of Salvia root P.E and nicotinic acid and/or niacinamide |
CN107648131A (en) * | 2017-11-24 | 2018-02-02 | 郑家伟 | A kind of Skin whitening care cosmeticses containing natural plant extracts |
CN108245469A (en) * | 2018-04-17 | 2018-07-06 | 刘瑞芳 | A kind of anti-aging skin care product |
CN108324647A (en) * | 2018-04-17 | 2018-07-27 | 刘瑞芳 | Skin care emulsion and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1457818A (en) * | 2002-05-16 | 2003-11-26 | 杨文志 | Poison expelling and astheniz resisting balance pill and its preparing method |
CN1660408A (en) * | 2003-12-31 | 2005-08-31 | 赵恒� | Medicine to be taken after being mixed in liquor of possessing bearutified and-faced effects |
-
2011
- 2011-11-14 CN CN2011103591419A patent/CN102366478B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1457818A (en) * | 2002-05-16 | 2003-11-26 | 杨文志 | Poison expelling and astheniz resisting balance pill and its preparing method |
CN1660408A (en) * | 2003-12-31 | 2005-08-31 | 赵恒� | Medicine to be taken after being mixed in liquor of possessing bearutified and-faced effects |
Non-Patent Citations (2)
Title |
---|
李建喜等: "活性氧自由基在动物机体内的生物学作用", 《动物医学进展》 * |
林远凤: "国内抗衰老中药概述", 《现代医药卫生》 * |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103263536A (en) * | 2013-02-04 | 2013-08-28 | 四川逢春制药有限公司 | Skin-whitening freckle-removing anti-aging composite and preparation method and application thereof |
CN103316150A (en) * | 2013-06-21 | 2013-09-25 | 四川逢春制药有限公司 | Composition for preventing aging and whitening skin as well as preparation method and application thereof |
CN103316150B (en) * | 2013-06-21 | 2015-06-03 | 四川逢春制药有限公司 | Composition for preventing aging and whitening skin as well as preparation method and application thereof |
CN105326686A (en) * | 2014-04-09 | 2016-02-17 | 赵月 | Whitening and moisturizing skin care mask |
CN105326686B (en) * | 2014-04-09 | 2018-02-09 | 广州重生化妆品实业有限公司 | A kind of skin whitening, moisturizing facial treatment mask |
CN103989164A (en) * | 2014-05-09 | 2014-08-20 | 深圳市皇都御颜养生科技有限责任公司 | Preparation method of anti-aging health food |
CN106794136B (en) * | 2014-10-10 | 2023-01-10 | 巴斯夫美容护理法国公司 | Deglycosylation of a combination of salvia miltiorrhiza extract and niacin and/or niacinamide |
CN106794136A (en) * | 2014-10-10 | 2017-05-31 | 巴斯夫美容护理法国公司 | The deglycosylation of the combination product of Salvia root P.E and nicotinic acid and/or niacinamide |
CN104840380A (en) * | 2015-01-21 | 2015-08-19 | 青岛科技大学 | Natural substance composition and application of same in whitening cosmetic |
CN105169064A (en) * | 2015-10-11 | 2015-12-23 | 淄博齐鼎立专利信息咨询有限公司 | Medicinal preparation for whitening skin |
CN107648131A (en) * | 2017-11-24 | 2018-02-02 | 郑家伟 | A kind of Skin whitening care cosmeticses containing natural plant extracts |
CN107648131B (en) * | 2017-11-24 | 2020-06-02 | 烟台市华昕生物医药科技有限公司 | A whitening skin care product containing natural plant extract |
CN111329812A (en) * | 2017-11-24 | 2020-06-26 | 郑家伟 | A whitening skin care product containing natural plant extract |
CN108324647A (en) * | 2018-04-17 | 2018-07-27 | 刘瑞芳 | Skin care emulsion and preparation method thereof |
CN108245469B (en) * | 2018-04-17 | 2021-06-11 | 深圳市中道美生物科技有限公司 | Anti-aging skin care product |
CN108324647B (en) * | 2018-04-17 | 2021-07-27 | 广州市帝臣日化科技有限公司 | Skin care emulsion and preparation method thereof |
CN108245469A (en) * | 2018-04-17 | 2018-07-06 | 刘瑞芳 | A kind of anti-aging skin care product |
Also Published As
Publication number | Publication date |
---|---|
CN102366478B (en) | 2013-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102366478B (en) | Composition for whitening skin and resisting senescence, preparation method and application thereof | |
CN111407678B (en) | Microemulsion with moisturizing, skin-brightening and anti-aging effects and preparation method thereof | |
CN102379984B (en) | Composition for delaying senility and whitening skin and preparation method and application thereof | |
CN105596243B (en) | A kind of Essence and facial mask containing nanogold and thermal water | |
CN110742843B (en) | Anti-aging traditional Chinese medicine extract of ginseng and glossy ganoderma as well as preparation method and application thereof | |
KR102381564B1 (en) | High yield ginsenoside biosynthesis inducing composition obtained from cultured ginseng callus cell of Korean and their uses | |
CN115444086A (en) | Health-care beverage with whitening and skin-brightening functions and preparation method and application thereof | |
CN103648514B (en) | Oral uptake skin improving agent | |
CN103316150B (en) | Composition for preventing aging and whitening skin as well as preparation method and application thereof | |
CN103860439B (en) | A kind of whitening skin and preserving moisture skin care compositions and preparation method thereof | |
CN112006205A (en) | Radix puerariae and dendrobium instant powder and preparation method thereof | |
CN102335217B (en) | Promoter for generation of glutathione | |
CN103263536A (en) | Skin-whitening freckle-removing anti-aging composite and preparation method and application thereof | |
CN105379887A (en) | Sweet osmanthus flowers tea with optimal antioxidation synergistic effect and preparation method as well as use thereof | |
KR101710142B1 (en) | Functional food composition comprising complex ferment consisting of soybean and barley | |
CN114831918A (en) | Traditional Chinese medicine composition fermentation liquor, preparation method and application thereof | |
CN105407871A (en) | Skin care composition | |
CN114376226A (en) | Peony flavone extract and preparation method and application thereof | |
KR20170021278A (en) | Functional food composition comprising complex ferment consisting of soybean and barley | |
CN103444952B (en) | Filamental flowering crab tea and aqueous extract thereof as well as application of aqueous extract | |
CN102397175A (en) | Chinese medicinal extract for eliminating face red blood streaks and preparation method and application thereof | |
CN101600416A (en) | A kind of skin care products synthetic and modulator approach thereof that contains the real product of ginseng adventitious root artificial culture tissue | |
CN103550304B (en) | There is blue lotus extract of antioxidation and moisturizing activity and its preparation method and application | |
CN105379888A (en) | Application of osmanthus tea with optimal antioxidation synergistic effect in preparation of health care products or food for regulating blood sugar level | |
CN105394770A (en) | Application of osmanthus tea having optimal antioxidant synergistic effect to preparation of anticancer health care products or food |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHEN HUAHUI Free format text: FORMER OWNER: SICHUAN FENGCHUN PHARMACEUTICAL CO. LTD. Effective date: 20140214 |
|
CB03 | Change of inventor or designer information |
Inventor after: Shen Huahui Inventor before: Zhong Maotuan Inventor before: Li Yong |
|
CB03 | Change of inventor or designer information | ||
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZHONG MAOTUAN LI YONG TO: SHEN HUAHUI Free format text: CORRECT: ADDRESS; FROM: 618100 DEYANG, SICHUAN PROVINCE TO: 224231 YANCHENG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140214 Address after: 224231 Dongtai city Jiangsu Sancang Town Village seven groups of 78 new homes Patentee after: Shen Huahui Address before: 618100 Yingbin Road, Nanhua Town, Zhongjiang County, Deyang, Sichuan, 9 Patentee before: Sichuan Fengchun Pharmaceutical Co., Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130403 Termination date: 20181114 |
|
CF01 | Termination of patent right due to non-payment of annual fee |